Acceptability, tolerability and safety of the BRIGhTMIND trial: Connectivity-guided intermittent theta-burst stimulation versus F3- repetitive transcranial magnetic stimulation for treatment-resistant depression

Background: The BRIGhTMIND study was a double-blind RCT comparing repetitive transcranial magnetic stimulation at a standard simulation site (the “F3” location given by the International 10–20 system, F3-rTMS) versus connectivity-guided intermittent theta burst stimulation (cgiTBS) for treatment-res...

Descripció completa

Dades bibliogràfiques

Autors principals:	Lucy Webster, Clement Boutry, Louise Thomson, Mohamed Abdelghani, Shaun Barber, Paul M. Briley, Micheal Kurkar, Sudheer Lankappa, R. Hamish McAllister-Williams, Ana Suazo Di Paola, Richard Morriss
Format:	Artigo
Idioma:	Inglês
Publicat:	Elsevier 2025-01-01
Col·lecció:	Comprehensive Psychiatry
Matèries:	Transcranial magnetic stimulation Depression Safety Acceptability Tolerability Treatment-resistant depression
Accés en línia:	http://www.sciencedirect.com/science/article/pii/S0010440X24000956
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!